Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
156.76
-1.42 (-0.90%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,602,259
Open
158.57
Bid (Size)
156.70 (5)
Ask (Size)
156.99 (5)
Prev. Close
158.18
Today's Range
156.50 - 158.69
52wk Range
144.95 - 175.97
Shares Outstanding
2,628,679,824
Dividend Yield
3.04%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer
Today 10:16 EDT
FDA's adcomm recommends expanded use of Bristol Myers Squibb's Abecma for triple-class exposed relapsed or refractory multiple myeloma, based on Phase 3 study results. Positive vote for Johnson &...
Via
Benzinga
Exposures
Product Safety
Bev Jennings selected as VIP Speaker at Global Women Thrive Summit 2024
March 16, 2024
The presentation is virtual and live in-person as part of a collaboration with the WBENC Amplify Conference in Denver, COJACKSONVILLE, Fla. & DENVER - March 16, 2024 - PRLog -- Bev Jennings, a VIP...
Via
PRLog
Topics
Supply Chain
Exposures
Supply Chain
Performance
YTD
-2.01%
-2.01%
1 Month
-0.70%
-0.70%
3 Month
+0.85%
+0.85%
6 Month
-3.51%
-3.51%
1 Year
+1.86%
+1.86%
More News
Read More
Analyzing NYSE:JNJ's Dividend Potential.
March 13, 2024
Via
Chartmill
Insights Into Johnson & Johnson's Performance Versus Peers In Pharmaceuticals Sector
March 11, 2024
Via
Benzinga
Guardians of Your Golden Years: 7 Stocks Every Retiree Needs to Own
March 16, 2024
Via
InvestorPlace
Meet the "Magnificent Seven" Stock That Pays More Dividends Than Any Other U.S.-Based Company
March 16, 2024
Via
The Motley Fool
Johnson & Johnson Stock Is Great. Here's Why You Shouldn't Buy It.
March 16, 2024
Via
The Motley Fool
The Taxman Cometh: 3 Stocks to Soften the Blow and Grow Your Dough
March 15, 2024
Via
InvestorPlace
Why Abbott's Formula-Related Sell-Off Could Be A Buying Opportunity, Says Analyst
March 15, 2024
Via
Investor's Business Daily
Topics
Death
Exposures
Death
Congressional Scrutiny Intensifies On Chinese Biotech Firms: WuXi AppTec Faces Biotech Exodus
March 14, 2024
Via
Benzinga
German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits
March 14, 2024
Via
Benzinga
Topics
Bankruptcy
Lawsuit
Exposures
Financial
Glyphosate
Legal
The 3 Most Undervalued Healthcare Stocks to Buy in March 2024
March 14, 2024
Via
InvestorPlace
Top Stock Reports For UnitedHealth, Johnson & Johnson & Oracle
March 13, 2024
Via
Talk Markets
FDA To Review Two Cell Therapies For Multiple Myeloma This Week - Johnson & Johnson And Bristol-Myers
March 13, 2024
Via
Benzinga
Exposures
Product Safety
3 No-Brainer Stocks to Buy With $300 Right Now
March 13, 2024
Via
The Motley Fool
7 High-Quality Blue-Chip Stocks to Buy if You’re Looking for Stability
March 12, 2024
Via
InvestorPlace
Golden Cross Alert: Johnson & Johnson Shines With Ambrx Deal, Bullish Technical Signal
March 12, 2024
Via
Benzinga
3 Must-Have Dividend Kings for a Steady Income Stream
March 12, 2024
Via
InvestorPlace
2 High-Yield Dow Jones Dividend Stocks to Buy Now and Hold Forever
March 12, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
March 11, 2024
From
Johnson & Johnson
Via
Business Wire
The Dow’s Best Friends: 3 ‘Dogs’ Ready to Fetch Huge Returns
March 11, 2024
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Wall Street Favorites: Why Analysts Love These 3 Blue-Chip Stocks
March 11, 2024
Via
InvestorPlace
3 Dividend Kings of Healthcare Stocks to Buy Hand Over Fist in March
March 11, 2024
Via
The Motley Fool
Pharma Stock Roundup: Novo Nordisk's New Obesity Pill Data, Roche, AstraZeneca's Pipeline Updates
March 09, 2024
Via
Talk Markets
Exposures
Product Safety
The Top 3 Pharma Stocks to Buy in March2024
March 09, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.